Gilead SciencesFRA:GIS -0.79%75 Forward Dividend Yield % is 2.61% as of Jun. 29, 2026. GuruFocus rates FRA:GIS with a GF Score™ of 75/100 and a GF Value™ of €81.25 (Significantly Overvalued). The stock has 3 warning signs investors should review. Among 505 Drug Manufacturers companies, Gilead Sciences ranks better than 57.23% on this metric.
As of today (2026-06-29), the Forward Annual Dividend Yield of Gilead Sciences is 2.61%.
As of today (2026-06-29), the Trailing Annual Dividend Yield of Gilead Sciences is 2.56%.
FRA:GIS's Forward Dividend Yield % is ranked better than 57.23% of 505
companies
in the Drug Manufacturers industry
Industry Median: 2.14
vs FRA:GIS: 2.61
During the past 12 months, Gilead Sciences's average Dividends Per Share Growth Rate was 2.90% per year.
During the past 3 years, the average Dividends Per Share Growth Rate was 2.70% per year.
During the past 5 years, the average Dividends Per Share Growth Rate was 3.00% per year.
During the past 10 years, the average Dividends Per Share Growth Rate was 7.80% per year.
During the past 13 years, the highest 3-Year average Dividends Per Share Growth Rate of Gilead Sciences was 20.90% per year. The lowest was 2.70% per year. And the median was 6.30% per year.
The growth rate is calculated with least square regression.
For more information regarding to dividend, please check our Dividend Page.
Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.
Dividends may also qualify a lower tax rate for investors.
In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.
Gilead Sciences Forward Dividend Yield % Related Terms
FRA:GIS vs PFE, AMGN, BMY: Forward Dividend Yield % Comparison
For the Drug Manufacturers - General subindustry, Gilead Sciences's Forward Dividend Yield %, along with its competitors' market caps and Forward Dividend Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Gilead Sciences Forward Dividend Yield % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Gilead Sciences's Forward Dividend Yield % distribution charts can be found below:
* The bar in red indicates where Gilead Sciences's Forward Dividend Yield % falls into.
Dividend Yield measures how much a company pays out in dividends each year relative to its share price.
Gilead Sciences Recent Full-Year* Dividend History
Amount
Ex-date
Record Date
Pay Date
Type
Frequency
Forex Rate
USD 0.820000
2026-06-15
2026-06-15
2026-06-29
Cash Dividend
quarterly
USD:EUR 0.856000
USD 0.820000
2026-03-13
2026-03-13
2026-03-30
Cash Dividend
quarterly
USD:EUR 0.865000
USD 0.790000
2025-12-15
2025-12-15
2025-12-30
Cash Dividend
quarterly
USD:EUR 0.854000
USD 0.790000
2025-09-15
2025-09-15
2025-09-29
Cash Dividend
quarterly
USD:EUR 0.852000
* GuruFocus has an internal rule that if the most recent dividend payment frequency is at least 4 times a year, then the full year will be calculated according to the frequency of payment or the one-year time frame, whichever is stricter.
* GuruFocus converts dividend currency to local traded share price currency in order to calculate dividend yield. Please refer to the last column "Forex Rate" in the above table.
Gilead Sciences's Forward Annual Dividend Yield (%) for Today is calculated as
Forward Annual Dividend Yield
=
Forward Full Year Dividend
/
Current Share Price
=
2.80768
/
108.26
=
2.59 %
Current Share Price is €108.26. Gilead Sciences's Dividends per Share for the forward twelve months is calculated as €0.70192 * 4 = €2.80768.
Gilead Sciences's Trailing Annual Dividend Yield (%) for Today is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Forward Dividend Yield % of 2.61% mean?
Gilead Sciences (FRA:GIS) has a Forward Dividend Yield % of 2.61% as of Jun. 29, 2026. Forward dividend yield is the ratio of company's expected dividends to the share price. View historical data on Gilead Sciences and its competitors. According to the industry distribution chart, Gilead Sciences ranks #216 out of 505 companies in the Drug Manufacturers industry, placing it in the top 42.8%.
Is Gilead Sciences' Forward Dividend Yield % too high?
Gilead Sciences' current Forward Dividend Yield % is 2.61%. The Drug Manufacturers industry median Forward Dividend Yield % is 2.14. Gilead Sciences' value of 2.61% is 22% above this industry median. Based on the distribution chart, Gilead Sciences ranks #216 out of 505 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, Gilead Sciences has a GF Score™ of 75/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Gilead Sciences' Forward Dividend Yield % compare to PFE and AMGN?
According to the Drug Manufacturers industry distribution chart, Gilead Sciences ranks #216 out of 505 companies for Forward Dividend Yield %. This puts Gilead Sciences in the upper half of its industry. The industry median Forward Dividend Yield % is 2.14. Gilead Sciences' value of 2.61% is 22% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Forward Dividend Yield % for a Drug Manufacturers company?
The median Forward Dividend Yield % among Drug Manufacturers companies is 2.14, based on 505 companies in the industry. Companies in the top quartile (top 25%) have a Forward Dividend Yield % significantly above this median, while those in the bottom quartile fall well below. However, Forward Dividend Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Gilead Sciences's current Forward Dividend Yield % of 2.61% is 22% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Forward Dividend Yield % mean?
A high Forward Dividend Yield % can signal that a stock is expensive relative to its fundamentals. Forward dividend yield is the ratio of company's expected dividends to the share price. View historical data on Gilead Sciences and its competitors. For the Drug Manufacturers industry, the median Forward Dividend Yield % is 2.14 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Gilead Sciences's current Forward Dividend Yield % is 2.61%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Gilead Sciences stock overvalued right now?
Based on GuruFocus' analysis, Gilead Sciences (FRA:GIS) is currently considered Significantly Overvalued. The stock's GF Value™ is €81.25, compared to a current price of €108.26 — trading 33.2% above its estimated fair value. The current Forward Dividend Yield % is 2.61% and 22% above the Drug Manufacturers industry median of 2.14. Gilead Sciences' overall GF Score™ is 75/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Forward Dividend Yield % calculated?
Forward Dividend Yield % is calculated from a company's financial statements. For Gilead Sciences (FRA:GIS), the current Forward Dividend Yield % is 2.61% as of Jun. 29, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Gilead Sciences (FRA:GIS) Overvalued in 2026?
Based on GuruFocus' analysis, Gilead Sciences stock appears to be overvalued.
The current stock price of €108.26 is trading 33.2% above its estimated GF Value™ of €81.25.
GuruFocus considers Gilead Sciences to be Significantly Overvalued.
Key valuation signals for FRA:GIS:
Forward Dividend Yield %: 2.61%
GF Value™: €81.25 vs. price of €108.26 (33.2% above fair value)
Industry Position: 22% above the Drug Manufacturers median (#216 of 505)
No single metric tells the full story. See the FRA:GIS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Gilead Sciences develops and markets therapies to treat and prevent life-threatening infectious diseases, with the core of its portfolio focused on HIV and hepatitis B and C. Gilead's acquisition of Pharmasset brought rights to hepatitis C drug Sovaldi, which is also part of newer combination regimens that remain standards of care. Gilead is also growing its presence in the oncology market via acquisitions, led by CAR-T cell therapy Yescarta/Tecartus (from Kite) and breast and bladder cancer therapy Trodelvy (from Immunomedics).
75GF Score
Get the complete analysis for FRA:GIS
Forward Dividend Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:GIS has been successfully added to your 